AOL Money & Finance

netl posts

Feed

Wireless tech trio: 'Killer apps are coming'

"We believe that the recent relative strength of tech stocks is the start of a longer term trend, not merely a flash in the pan," says Jim Oberweis and Dave Covas.

In The Oberweis Report, the money managers and small cap advisors explain, "Our confidence stems from the emergence of the next Killer Apps, which drive technology cycles because they change how we live our lives." Here, they make a case for technology and offer a trio of small cap favorites.

"During the 1980's and early 1990's, the personal computer was the Killer App. During the late 1990's, it was the Internet. During this decade – zilch. Until now. The next Killer Apps – video-on-demand and ubiquitous high-speed wireless connectivity – are coming.

Continue reading Wireless tech trio: 'Killer apps are coming'

Analyst upgrades, downgrades and initiations: DELL, IBM, IPCR, NETL ...

Analyst upgrades:
  • Citigroup upgraded MEMC Electronic (NYSE: WFR) to Buy from Hold after channel checks indicated solar poly price pressures are easing. The firm added MEMC to its Top Picks Live list and raised its price target on shares to $24 from $15.
  • FBR Capital upgraded PHH Corp (NYSE: PHH) to Outperform from Market Perform to reflect an improvement in mortgage banking fundamentals and recent management changes at the company. The firm raised its target on shares to $23 from $13.
  • Deutsche Bank upgraded PerkinElmer (NYSE: PKI) to Hold from Sell on valuation, seeing a balanced risk/reward at current levels. The firm raised its target on shares to $19 from $14.
  • Pearson plc (NYSE: PSO) was upgraded to Outperform from Neutral at Credit Suisse.
  • Dell (NASDAQ: DELL) was upgraded to Conviction Buy from Neutral at Goldman.
  • Nymagic (NYSE: NYM) was upgraded to Market Perform from Underperform at Keefe Bruyette.

Continue reading Analyst upgrades, downgrades and initiations: DELL, IBM, IPCR, NETL ...

Analyst upgrades, downgrades and initiations: CAL, NETL, MAPP, DDUP, LMT ...

Analyst upgrades:
  • Jefferies upgraded MDS Inc. (NYSE: MDZ) to Buy from Hold on valuation as it believes shares are pricing in a "worst case" scenario at current levels. The firm keeps a $6.50 target on the stock.
  • JP Morgan upgraded Continental (NYSE: CAL) to Overweight from Neutral on valuation as it believes the recent sell-off is overdone. The firm keeps a $13 price target on the stock.
  • Thomas Weisel is positive on Allergan's (NYSE: AGN) diverse product portfolio, global infrastructure, vertical integration, and deep pipeline. The firm upgraded shares to Overweight from Market Weight and has a $54 target on the stock.
  • NetLogic (NASDAQ: NETL) was upgraded to Buy from Neutral at Piper.
  • Dover (NYSE: DOV) was raised to Buy from Neutral at Banc of America/Merrill.
  • Map Pharmaceuticals (NASDAQ: MAPP) was upgraded at Argus to Hold from Sell.

Continue reading Analyst upgrades, downgrades and initiations: CAL, NETL, MAPP, DDUP, LMT ...

Analyst upgrades, downgrades and initiations: JCP, NVLS, CAG, RJF, PCG, STP, AMZN, MS, MSFT

Analyst upgrades:
  • JP Morgan upgraded J.C. Penney (NYSE: JCP) to Neutral from Underweight based on lower input costs, stabilization in home, lower markdown dollars, and valuation.
  • Oppenheimer upgraded Novellus (NASDAQ: NVLS) to Perform from Underperform as it believes Novellus' market share has stabilized and that the company is a potential acquisition target. The firm raised its price target to $20 from $9.
  • Bernstein upgraded ConAgra (NYSE: CAG) to Market Perform from Underperform citing strength in grains and moderating input costs.
  • ConocoPhillips (NYSE: COP) was raised to Buy from Neutral at Goldman.
  • China Housing (NASDAQ: CHLN) was upgraded to Buy from Hold at Roth Capital.

Continue reading Analyst upgrades, downgrades and initiations: JCP, NVLS, CAG, RJF, PCG, STP, AMZN, MS, MSFT

Analyst upgrades, downgrades and initiations: TASR, M, FDO, NVDA, DGX ...

Analyst upgrades:
  • Merriman upgraded Taser (NASDAQ: TASR) to Buy from Neutral as it believes current valuation levels do not reflect the company's market opportunities and that the law enforcement funding in President Obama's stimulus plan will boost sales in Q4 and FY10.
  • Goldman upgraded Macy's (NYSE: M) to Buy from Neutral and added shares to its Conviction Buy List based on reduced balance sheet concerns and improved risk/reward. The firm also raised their target to $8.25 from $8.
  • JP Morgan upgraded Family Dollar (NYSE: FDO) to Neutral from Underweight and raised its target to $29 from $19 following the better-than-expected Q2 report. The analyst continues to prefer Dollar Tree (NASDAQ: DLTR) and Wal-Mart (NYSE: WMT).
  • Goldman removed Universal Am (NYSE: UAM) from the Conviction Sell List.
  • McDermott (NYSE: MDR) was upgraded to Buy from Hold at Jefferies.
  • Canadian Natural (NYSE: CNQ) was upgraded to Sector Outperformer from Sector Performer at CIBC.

Continue reading Analyst upgrades, downgrades and initiations: TASR, M, FDO, NVDA, DGX ...

Analyst upgrades, downgrades and initiations: ANF, WFMI, MIC, SNY, BMY, PFE, JNJ ...

Analyst upgrades:
  • Jefferies upgraded shares of Abercrombie & Fitch (NYSE: ANF) to Hold from Underperform on valuation. The stock has gone down 40% since they initiated coverage on September 19. The firm maintains a $29 target.
  • Citigroup upgraded EOG Resources (NYSE: EOG), Quicksilver (NYSE: KWK) and Southwestern Energy (NYSE: SWN) to Buy from Hold on their belief U.S. natural gas-focused E&P companies have near-term upside.
  • Barclays upgraded Whole Foods (NASDAQ: WFMI) to Equal Weight from Underweight citing the $425M private equity investment, which reduces liquidity risk, and its reduced cost structure.
  • Brandywine Realty (NYSE: BDN) and AvalonBay (NYSE: AVB) were upgraded to Neutral from Underperform at Merrill Lynch.
  • tw telecom (NASDAQ: TWTC) was upgraded to Neutral from Underweight at JP Morgan.
  • AmeriCredit (NYSE: ACF) was upgraded to Market Perform from Underperform at Friedman Billings.
Analyst downgrades:
  • Jefferies downgraded Macquarie Infrastructure (NYSE: MIC) to Hold from Buy to reflect the company's sensitivity to the economic slowdown and funding risk. The firm lowered their target to $9 from $40 after the company announced a dividend reduction.
  • Sanofi-Aventis (NYSE: SNY) was cut to Sell from Neutral at UBS due to the company's exposure to potential generic competition and a lack of new products.
  • Friedman Billings downgraded Cleveland Cliffs (NYSE: CLF) to Market Perform from Outperform and lowered their target to $42 from $50 to reflect the risk of further production cuts.
  • Credit Suisse lowered Acme Packet (NASDAQ: APKT) to Neutral from Outperform.
  • Delta Petroleum (NASDAQ: DPTR) was downgraded at Deutsche Bank to Sell from Hold.
  • Siemens (NYSE: SI) was downgraded to Sell from Buy at UBS.
Analyst initiations:
  • Goldman initiated Bristol-Myers (NYSE: BMY) with a Buy rating and $27 target as they believe it is making progress in becoming a mid-sized specialty biopharmaceutical company. The firm expects the company to be active in M&A and to spin-off or divest its slow-growth or fast-growing assets, such as virology and oncology.
  • Goldman believes Pfizer (NYSE: PFE) needs a "radical transformation" and restructuring that includes a break up, spin and merger in order to outperform over the next several years. Shares were assumed with a Sell rating and $19 target.
  • Johnson & Johnson (NYSE: JNJ) was initiated with a Neutral rating and $65 target at Banc of America. The firm prefers to be on the sidelines given uncertainties surrounding 2009 revenue growth and the potential for negative rhetoric out of Washington on pharma costs.
  • Acorda (NASDAQ: ACOR) was started at RBC Capital with an Outperform rating and $30 target.
  • Cavium Networks (NASDAQ: CAVM) and NetLogic (NASDAQ: NETL) were initiated with Neutral ratings at Cowen.
  • Edwards Lifesciences (NYSE: EW) was assumed with a Buy rating and $61 target at Piper Jaffray.

Emerging strength in networking stocks

This post was written by Minyanville contributor Sean Udall.

Net Logic Microsystems, Inc. (NASDAQ: NETL), like Cavium Networks, Inc. (NASDAQ: CAVM), reported good enough numbers to really push the stock meaningfully higher today. Generally speaking high end and edge networking are holding up as well as any area in technology. Later this quarter we get to hear Cisco Systems, Inc. (NASDAQ: CSCO), who sounded the first alarm late last year.

To get a solid continuation of this networking emerging strength (fundamentally), we will need to hear something like this from CSCO later this quarter. "While sluggish conditions were exacerbated by the credit turmoil hitting the financial enterprise segment, we are standing by our prior assessment and feel the growth of the intelligent network and the profound growth in video traffic will still result in a relatively short downturn. Further, while we cannot tell with certainty, we feel we could see better order rates resuming in the first half of 2009."

A statement like that combined with some credit fuel and the networking group may again be one of the better performing sub-groups in tech.

Analyst calls: GM, F, CB, MER, LLY, UL, BRCM, AAPL, PALM ...

Analyst upgrades:
  • Merrill upgraded shares of General Motors (NYSE: GM) and Ford (NYSE: F) to Neutral from Underperform on expectations for fundamentals to improve in 2009.
  • Citigroup upgraded Chubb (NYSE: CB) and Travelers Group (NYSE: TRV) to Buy from Hold as they expect the company to benefit from the AIG (NYSE: AIG) fallout. The firm raised Chubb's target to $57 from $56 and Travelers Group's target to $51.50 from $49.50.
  • Credit Suisse upgraded shares of SAP AG (NYSE: SAP) to Outperform from Neutral as they believe margin expansion can drive higher profitability.
  • JetBlue (NASDAQ: JBLU) was upgraded to Buy from Hold at Argus.
  • Goldman raised Merrill Lynch (NYSE: MER) to Neutral from Sell.
  • NetLogic (NASDAQ: NETL) was upgraded to Buy from Neutral at Piper.
Analyst downgrades:
  • JP Morgan downgraded Eli Lilly (NYSE: LLY) to Underweight from Neutral citing the company's early stage pipeline and generic competition.
  • Merrill downgraded Unilever (NYSE: UL) to Neutral from Buy as they believe the incoming CEO is unlikely to bring a major restructuring or split up the company.

Continue reading Analyst calls: GM, F, CB, MER, LLY, UL, BRCM, AAPL, PALM ...

Analyst initiations: WX, AAPL and DNA

MOST NOTEWORTHY: WuXi Pharma, Apple and Genentech were today's noteworthy initiations:
  • Global Hunter expects WuXi Pharma (NYSE:WX) to remain under pressure in the near-term due to gross margin constraints and dilution risk from the AppTec acquisition. The firm finds the stock fairly valued at current levels and initiated shares with a Neutral rating.
  • ThinkPanmure assumed Apple (NASDAQ:AAPL) with a Buy rating and $225 target and recommends investors take advantage of recent weakness to build core positions.
  • Genentech (NYSE:DNA) was started at Deutsche Bank with a Buy rating and $83 target. The firm sees limited downside and the potential for significant upside if Avastin works in adjuvant colon cancer.
OTHER INITIATIONS:

Symbol Lookup
IndexesChangePrice
DJIA+73.0010,270.47
NASDAQ+18.862,167.88
S&P 500+6.241,093.48

Last updated: November 15, 2009: 08:17 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance